Table 2.
Univariable | Multivariable | |||
---|---|---|---|---|
β Estimate (95% CI) | P values | β Estimate (95% CI) | P values | |
Total group | ||||
FEV1, L | 0.008(−0.003~0.02) | 0.157 | 0.02(0.001~0.02) | 0.025 |
FEV1pred,% | 0.15(−0.25~0.55) | 0.465 | 0.32(−0.06~0.69) | 0.097 |
FVC, L | 0.01(−0.001~0.03) | 0.063 | 0.02(0.002~0.03) | 0.022 |
FVCpred,% | 0.15(−0.24~0.54) | 0.458 | 0.26(−0.11~0.63) | 0.170 |
FEV1/FVC,% | −0.01(−0.20~0.17) | 0.893 | 0.07(−0.10~0.25) | 0.416 |
GOLD 1 | ||||
FEV1, L | 0.01(−0.003~0.02) | 0.123 | 0.01(0.001~0.02) | 0.032 |
FEV1pred,% | 0.16(−0.15~0.48) | 0.308 | 0.25(−0.06~0.04) | 0.117 |
FVC, L | 0.02(−0.002~0.04) | 0.076 | 0.01(0.00~0.03) | 0.054 |
FVCpred,% | 0.16(−0.28~0.60) | 0.473 | 0.24(−0.17~0.66) | 0.254 |
FEV1/FVC,% | −0.03(−0.16~0.10) | 0.660 | 0.03(−0.1~0.15) | 0.686 |
GOLD 2 | ||||
FEV1, L | 0.004(−0.01~0.02) | 0.451 | 0.01(−0.003~0.01) | 0.215 |
FEV1pred,% | 0.05(−0.22~0.32) | 0.716 | 0.08(−0.19~0.35) | 0.561 |
FVC, L | 0.004(−0.02~0.02) | 0.702 | 0.01(−0.01~0.02) | 0.515 |
FVCpred,% | −0.05(−0.45~0.35) | 0.791 | −0.05(−0.45~0.36) | 0.825 |
FEV1/FVC,% | 0.07(−0.19~0.34) | 0.580 | 0.09(−0.18~0.35) | 0.517 |
GOLD 3–4 | ||||
FEV1, L | 0.01(−0.007~0.02) | 0.284 | 0.01(−0.01~0.03) | 0.298 |
FEV1pred,% | 0.16(−0.36~0.69) | 0.537 | 0.27(−0.30~0.84) | 0.343 |
FVC, L | 0.03(−0.012~0.07) | 0.155 | 0.03(−0.02~0.07) | 0.222 |
FVCpred,% | 0.61(−0.45~1.66) | 0.253 | 0.69(−0.48~1.86) | 0.241 |
FEV1/FVC,% | −0.21(−0.69~0.27) | 0.389 | −0.11(−0.63~0.41) | 0.667 |
Notes: P values marked bold indicate that the value is statistically significant. Multivariable linear regression analysis models were adjusted for age, sex, BMI, smoking status, smoke index, passive smoker, occupational exposure, comorbidities and family history of respiratory diseases. β estimates from Multivariate linear regression analysis were the unstandardized β estimates. Other abbreviations see Table 1.
Abbreviation: CI, confidence interval.